Latest kidney cancer news
All.Can UK Working Group
Action Kidney Cancer is a member of the All.Can UK [...]
Cancer52 All Member Meeting
The latest Cancer52 All Member Meeting took place on 19 [...]
Immunotherapy after progression of metastatic kidney cancer
Vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKI) are [...]
Ethnic disparities in cancer
Cancer Research UK has looked at data from the NHS [...]
NHS England campaign to combat fear of cancer
NHS England has launched a new campaign to tackle the [...]
ASCO GU 2022: Patient-reported experience of kidney cancer from the IKCC
The incidence of renal cell carcinoma (RCC) is rising globally, [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo kidney cancer sunitinib cabozantinib Sutent progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx axitinib COVID-19 cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus risk factors Yervoy adjuvant therapy Keytruda targeted therapy metastases papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
